Skip to content

Clinical trials

Terminated Lung Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Terminated Country / region: Canada Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20062
20072
20081
20093
20113
20144
20152
20173
20182
20192
20202
20213
20222
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
AHS Cancer Control Alberta2
Blueprint Medicines Corporation2
McMaster University2
Ontario Clinical Oncology Group (OCOG)2
Pharmacyclics LLC.2
Abbott1
Alliance for Clinical Trials in Oncology1
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms42
Carcinoma, Non-Small-Cell Lung21
Breast Neoplasms6
Neoplasms5
Bronchial Neoplasms4
Colorectal Neoplasms4
Lung Diseases4
Neoplasm Metastasis4
Neoplasms by Site4
Respiratory Tract Diseases4

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.